What's new

EMEA-003393-PIP01-23

EMEA-003393-PIP01-23

Jun 10, 2025 - 13:45
 0
EMEA-003393-PIP01-23
EMEA-003393-PIP01-23
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, ...

Next Article

EMEA-003333-PIP01-22

Related Posts

Human medicines European public assessment report (EPAR): Eucreas, vildagliptin,metformin, Date of authorisation: 14/11/2007, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0

Orphan designation: genetically modified replication-incompetent herpes simplex virus-1 expressing collagen VII (beremagene geperpavec) Treatment of epidermolysis bullosa, 16/04/2018 Positive

Orphan designation: genetically modified replication-in...

Jun 10, 2025  0

Human medicines European public assessment report (EPAR): Supemtek Tetra (previously Supemtek), quadrivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 16/11/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 22, 2025  0